LUMELung1_2A: LUMELung1, figure 2A

LUMELung1_2AR Documentation

LUMELung1, figure 2A

Description

Kaplan-Meier digitized data from LUMELung1, figure 2A (PMID 24411639). A reported sample size of 655 for a primary endpoint of PFS in lung cancer.

Usage

LUMELung1_2A

Format

A data frame of 1,134 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (docetaxel_nintedanib, docetaxel_placebo)

Source

Reck M, Kaiser R, Mellemgaard A, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 2014; 15: 143–55.

Examples

summary(LUMELung1_2A)

kmplot(LUMELung1_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.